The PI3K/Akt pathway, which is abnormally activated in the phosphatidylinositol 3-kinase (PI3K) malignancies and essential for many cellular functions, promotes the growth and development of tumours. It may be possible to fully understand the role of this pathway by looking at its upstream and downstream nodes. The development of new cancer drugs may benefit from techniques that target the pathway's primary constituents in light of mounting evidence